Back To: Home : Featured Technology : High Throughput Screening

CLICK HERE FOR WHAT'S NEW IN:
 

New high-throughput platform for immuno-oncology research
May 2016
SHARING OPTIONS:

Horizon Discovery
 
Horizon Discovery has introduced a new platform for immuno-oncology research. The platform consists of several high-throughput assays that enable researchers to test thousands of potential anticancer drugs that recruit the body’s own immune system to fight cancer.
 
Horizon’s new platform enables researchers to study how new drugs are able to activate different types of immune cells as well as increase their ability to kill tumors. The platform includes high-throughput ADCC, CDC, primary T cell activation, mixed lymphocyte reaction and T cell-mediated tumor lysis assays in 384-well format, allowing researchers to test hundreds of new drugs simultaneously.
 
Horizon Discovery
www.horizondiscovery.com

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.